These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19589033)

  • 1. Additional therapy for high-risk prostate cancer treated with surgery: what is the evidence?
    Morgan SC; Dearnaley DP
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):939-51. PubMed ID: 19589033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis.
    Cheng X; Wang ZH; Peng M; Huang ZC; Yi L; Li YJ; Yi L; Luo WZ; Chen JW; Wang YH
    Asian J Androl; 2020; 22(4):383-389. PubMed ID: 31603140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of progressive, locally advanced prostate carcinoma].
    Niesel T; Breul J; Hartung R
    Urologe A; 1998 Mar; 37(2):145-8. PubMed ID: 9563123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant and adjuvant treatment in high-risk prostate cancer.
    Bandini M; Fossati N; Gandaglia G; Preisser F; Dell'Oglio P; Zaffuto E; Stabile A; Gallina A; Suardi N; Shariat SF; Montorsi F; Karakiewicz PI; Briganti A
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):425-438. PubMed ID: 29355037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of definitive external beam radiation therapy in the treatment of prostate cancer.
    Daly T
    World J Urol; 2020 Mar; 38(3):565-591. PubMed ID: 30850855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prostate cancer conundrum.
    Albertsen PC
    J Natl Cancer Inst; 2003 Jul; 95(13):930-1. PubMed ID: 12837821
    [No Abstract]   [Full Text] [Related]  

  • 7. Why does androgen deprivation enhance the results of radiation therapy?
    Wo JY; Zietman AL
    Urol Oncol; 2008; 26(5):522-9. PubMed ID: 18774467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer.
    Gomella LG; Zeltser I; Valicenti RK
    Urology; 2003 Dec; 62 Suppl 1():46-54. PubMed ID: 14747041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Approaches Prior To Radical Prostatectomy.
    Ryan ST; Patel DN; Parsons JK; McKay RR
    Cancer J; 2020; 26(1):2-12. PubMed ID: 31977379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical radiotherapy for prostate cancer.
    Parker CC; Dearnaley DP
    Cancer Treat Rev; 2003 Jun; 29(3):161-9. PubMed ID: 12787711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy Strategies as Primary Treatment for High-risk Localized Prostate Cancer: A Systematic Review and Meta-analysis.
    Greenberger BA; Zaorsky NG; Den RB
    Eur Urol Focus; 2020 Mar; 6(2):404-418. PubMed ID: 31813810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer.
    Linder BJ; Boorjian SA; Umbreit EC; Carlson RE; Rangel LJ; Bergstralh EJ; Karnes RJ
    Int J Urol; 2013 Aug; 20(8):798-805. PubMed ID: 23278850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.
    Denham JW; Steigler A; Lamb DS; Joseph D; Turner S; Matthews J; Atkinson C; North J; Christie D; Spry NA; Tai KH; Wynne C; D'Este C
    Lancet Oncol; 2011 May; 12(5):451-9. PubMed ID: 21440505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy as primary treatment of high-risk prostate cancer.
    Ingels A; de la Taille A; Ploussard G
    Curr Urol Rep; 2012 Apr; 13(2):179-86. PubMed ID: 22314881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.
    Wilt TJ; MacDonald R; Rutks I; Shamliyan TA; Taylor BC; Kane RL
    Ann Intern Med; 2008 Mar; 148(6):435-48. PubMed ID: 18252677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The status of surgery in the management of high-risk prostate cancer.
    Bach C; Pisipati S; Daneshwar D; Wright M; Rowe E; Gillatt D; Persad R; Koupparis A
    Nat Rev Urol; 2014 Jun; 11(6):342-51. PubMed ID: 24818848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the primary in metastatic prostate cancer.
    Gîngu C; Heidenreich A; Andreşanu A; Mihancea A; Sinescu I; Baston C
    Curr Opin Urol; 2020 Jul; 30(4):566-575. PubMed ID: 32452998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant medical treatment or radiotherapy following radical prostatectomy or curative radiotherapy].
    Guy L
    Bull Cancer; 2007 Jul; 94(7 Suppl):F15-20. PubMed ID: 17845989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
    Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Sedlmayer F; Wenz F; Zips D; Wiegel T;
    Strahlenther Onkol; 2018 Jul; 194(7):619-626. PubMed ID: 29383406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.
    Touijer KA; Karnes RJ; Passoni N; Sjoberg DD; Assel M; Fossati N; Gandaglia G; Eastham JA; Scardino PT; Vickers A; Cozzarini C; Montorsi F; Briganti A
    Eur Urol; 2018 Jun; 73(6):890-896. PubMed ID: 29042125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.